These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12359017)

  • 1. Celecoxib, safe in NSAID intolerance.
    García-Rodríguez RM; Hinojosa M; Camacho-Garrido E; Berges Gimeno P; Martín García C
    Allergy; 2002 Nov; 57(11):1085-6. PubMed ID: 12359017
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 4. [The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs].
    Ahlbach S; Usadel KH; Kaufmann R; Boehncke WH
    Med Klin (Munich); 2003 Apr; 98(5):242-4. PubMed ID: 12721666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urticaria and angioedema from cyclooxygenase-2 inhibitors.
    Kelkar PS; Butterfield JH; Teaford HG
    J Rheumatol; 2001 Nov; 28(11):2553-4. PubMed ID: 11708434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib approved as NSAID with some concessions on class warning.
    Miller JL
    Am J Health Syst Pharm; 1999 Mar; 56(5):403. PubMed ID: 10096694
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute onset of auditory hallucinations after initiation of celecoxib therapy.
    Lantz MS; Giambanco V
    Am J Psychiatry; 2000 Jun; 157(6):1022-3. PubMed ID: 10831492
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance.
    Celik G; Paşaoğlu G; Bavbek S; Abadoğlu O; Dursun B; Mungan D; Misirligil Z
    J Asthma; 2005 Mar; 42(2):127-31. PubMed ID: 15871445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib. Results of oral provocation tests in patients with NSAID hypersensitivity.
    Kruse R; Ruzicka T; Grewe M
    Acta Derm Venereol; 2003; 83(3):183-5. PubMed ID: 12816152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity?
    Çelik GE; Erkekol FÖ; Aydın Ö; Demirel YS; Mısırlıgil Z
    Allergol Immunopathol (Madr); 2013; 41(3):181-8. PubMed ID: 23031659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain management in patients with osteoarthritis.
    Finucane TE
    JAMA; 2003 Jul; 290(1):36; author reply 36. PubMed ID: 12837705
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance.
    Bavbek S; Celik G; Ediger D; Mungan D; Demirel YS; Misirligil Z
    J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone.
    Wyplosz B; Vautier S; Lillo-Le Louët A; Capron L
    Br J Clin Pharmacol; 2006 Apr; 61(4):474. PubMed ID: 16542210
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)].
    Boehncke S; Boehncke WH
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2249-52. PubMed ID: 16208597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE.
    Lander SA; Wallace DJ; Weisman MH
    Lupus; 2002; 11(6):340-7. PubMed ID: 12139371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
    Gyllfors P; Bochenek G; Overholt J; Drupka D; Kumlin M; Sheller J; Nizankowska E; Isakson PC; Mejza F; Lefkowith JB; Dahlén SE; Szczeklik A; Murray JJ; Dahlén B
    J Allergy Clin Immunol; 2003 May; 111(5):1116-21. PubMed ID: 12743579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Celecoxib in NSAID-induced cutaneous and respiratory adverse reactions].
    Valero A; Enrique E; Baltasar M; Cisteró A; Martí E; Picado C
    Med Clin (Barc); 2003 Nov; 121(18):695-6. PubMed ID: 14651817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.